A carregar...
Thromboprophylaxis in a patient with COVID‐19 and severe hemophilia A on emicizumab prophylaxis
COVID‐19 can be associated with coagulopathy (CAC, COVID‐19‐associated coagulopathy) with a high prothrombotic risk based on an intense inflammatory response to viral infection leading to immunothrombosis through different procoagulant pathways. Emerging evidence suggests that the use of heparin in...
Na minha lista:
| Publicado no: | J Thromb Haemost |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307111/ https://ncbi.nlm.nih.gov/pubmed/32526092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14954 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|